Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

  • 05/27/2022 - Seminar Series: Telehealth & Primary Care
    March 1, 2022 by User Not Found
    Hear about telehealth and its impacts on primary care delivery.
  • 05/13/2022 - Seminar Series: Vaccine Hesitancy & Communication Strategies
    March 1, 2022 by User Not Found
    Learn about vaccination hesitancy and the communication strategies that may help us overcome those hurdles.
  • 04/22/2022 - Seminar Series: Extension's Approach to the COVID-19 Pandemic
    March 1, 2022 by User Not Found
    Learn how America’s farmers, ranchers and foresters have fared compared to those in other countries because of Extension worker effort to address the needs of local communities of service. How did changes brought on by the pandemic impact Extensions, and how will they be integrated into our new normal?
  • 04/08/2022 - Seminar Series: COVID & Child Health Services
    March 1, 2022 by User Not Found
    Learn from regional experts in pediatrics on the impact of the COVID-19 pandemic on child health care accessibility, delivery, and best practices.
  • 03/25/2022 - Seminar Series: Tri-State Cancer Plan
    March 1, 2022 by User Not Found
    Learn about your state’s cancer plan, core priorities, and target populations, their approach for facilitating cancer prevention and control actions, examples of collaborative activities, and plans for recovering, sustaining and accelerating the momentum in cancer prevention.
  • Consistent Treatment Improves Health Outcomes for Pregnant Persons with OUD
    March 1, 2022 by User Not Found
    Opioid use disorder (OUD) has been declared a public health crisis in the northern New England states for years, and one population requires particular care: pregnant patients. In 2018, only about half of pregnant persons were receiving consistent treatment, while another quarter had inconsistent treatment. Increasing these numbers would be essential to supporting pregnant patients with OUD, and Drs. Katherine Ahrens of USM and Marjorie Meyer of UVM aim to do just that.
  • Telemedicine Lessons Foreshadowed by Pre-Pandemic Cancer Telegenetics
    March 1, 2022 by User Not Found
    In 2018, telemedicine was not at the forefront in medicine for many, but some knew that for our rural communities, it could make a world of difference. Drs. Susan Miesfeldt of Maine Medical Center/MaineHealth and Nan Solomons of the University of New England assessed whether cancer genetic services were equally effective via telehealth consults as in-person appointments from the patient’s point of view. Their study highlighted both the need and benefits of telemedicine for remote patients far before the pandemic came into play.
  • Celebration of Gender Equity Highlights Data & Advocacy, Recognizes Champions
    February 28, 2022 by Jennifer Nachbur
    The Larner College of Medicine Office of Diversity, Equity and Inclusion hosted the third annual Celebration of Gender Equity in Medicine and Science on March 3, 2022.
  • Students Contribute to COVID-19 Research
    February 28, 2022 by Division of Surgical Research
    Undergraduate students strive to understand COVID-19 vaccines in a UVM lab under Larner College of Medicine surgery professor Dr. Dev Majumdar. Students of each graduating class work in the lab. Split into two components, half of the researchers work on mRNA vaccine development and half learn as much as they can about how COVID-19 works, Majumdar said.
    Read full story at THEVERMONTCYNIC
  • New Study Highlights Colorectal Cancer Treatments that Improve Patients' Quality of Life
    February 28, 2022 by Kate Strotmeyer
    In recent years, total neoadjuvant treatment—a potent new therapy for advanced colorectal cancer—has emerged as the standard of care. But the treatment can be harsh, impacting quality of life for many patients. A new study published in Clinical Colorectal Cancer by a team of researchers affiliated with the University of Vermont Cancer Center highlights a variety of new colorectal cancer treatments that take into account both a patient’s likely health outcome and quality of life factors.
  • Bundock Quoted in Regional Newspapers about New England COVID-19 Death Certificates
    February 24, 2022 by Lucy Gardner Carson
    (FEBRUARY 24, 2022) Vermont Chief Medical Examiner Elizabeth Bundock, M.D., Ph.D., clinical assistant professor of pathology and laboratory medicine, spoke about the importance of accuracy in death certificate records in a news story in the Providence Journal.
  • Heart Month: Bouncing Back after Atypical Heart Attack
    February 23, 2022 by Roland Kielman and Jennifer Nachbur
    A heart attack struck 44-year-old Sara Rutledge during her daily run. Thanks to the competence and care of a team of clinicians at Central Vermont Medical Center and UVM Medical Center, she received a diagnosis for spontaneous coronary artery dissection - or SCAD - has had a successful recovery, and is back to doing her favorite activities.
  • Menson & Kaminsky Featured in VTDigger Story on Long-COVID Research
    February 22, 2022 by Lucy Gardner Carson
    (FEBRUARY 22, 2022) Pulmonologists David Kaminsky, M.D., professor of medicine, and Katherine Menson, D.O., assistant professor of medicine, spoke with Mike Dougherty of VTDigger for a story titled “Vermonters with ‘Long Covid’ Still Face Barriers to Care.”
  • Anker Discusses Colon Cancer Treatment Research on WCAX-TV
    February 18, 2022 by Jennifer Nachbur
    (FEBRUARY 18, 2022) Associate Professor of Radiology Christopher Anker, M.D., a radiation oncologist at UVM Medical Center, discussed his and colleague's study in the journal Clinical Colorectal Cancer on local CBS affiliate WCAX-TV.
  • UVM Cancer Researcher Frances Carr Elected AAAS Fellow
    February 16, 2022 by Jennifer Nachbur
    Frances Carr, Ph.D., professor of pharmacology at the Larner College of Medicine at the University of Vermont and UVM Cancer Center member, has been elected to the American Association for the Advancement of Science Fellows Class of 2021.
  • Teaching Academy Snow Season Retreat Celebrates Medical Education Excellence
    February 9, 2022 by Jennifer Nachbur
    University of Vermont Larner College of Medicine faculty, leaders, and colleagues gathered virtually for the Teaching Academy’s 2022 Snow Season Education Retreat January 20-21. Highlights of the two-day event included a plenary session by representatives of the Kern National Network for Caring and Character in Medicine, the Induction and Award Ceremony, and an in-person poster session.
  • Davidson Invested as Inaugural Schapiro-Carroll Green and Gold Professor of Anesthesiology
    February 8, 2022 by Jennifer Nachbur
    In a ceremony held February 7, 2022, Melissa Davidson, M.D., a faculty physician leader at the University of Vermont’s Larner College of Medicine, was invested as the inaugural holder of the Howard Schapiro, M.D.’80 and Janet Carroll, M.S.N., M.P.H., Green & Gold Professorship in Anesthesiology.
  • Higgins’ Contingency Management Work in The Guardian Article
    February 8, 2022 by Lucy Gardner Carson
    (FEBRUARY 8, 2022) A contingency management program developed by psychologist Stephen Higgins, Ph.D., professor of psychiatry, to treat patients with addictions was mentioned in The Guardian.
  • UVM Cancer Center Investigators Publish the Breast Pre-Cancer Atlas
    January 18, 2022 by Kate Strotmeyer
    UVM Cancer Center researchers contributed to the establishment of a breast pre-cancer atlas, which establishes the molecular and cellular properties of early-stage breast cancer and is the result of a six-year, National Cancer Institute-funded, collaborative initiative.
  • CVRI Viridis Montis Challenge Highlights Early-Career Researchers
    February 3, 2022 by User Not Found
    Cardiac remodeling, chronic kidney disease, brain cell energy generation, hypertension and stroke risk, and socioeconomic status and cardiac rehabilitation outcomes, were the topics presented at the Cardiovascular Research Institute of Vermont’s annual Viridis Montis Early Career Investigator Challenge on February 2, 2022.